Title : Management of hepatitis C infection before and after liver transplantation.

Pub. Date : 2015 Apr 21

PMID : 25914454






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Currently, interferon (IFN)-based regimens can be used in dual-agent regimens with ribavirin, in triple-agent antiviral strategies with direct-acting antivirals (e.g., protease inhibitors telaprevir or boceprevir), or before transplant in compensated patients to reduce HCV viral load to prevent or reduce the risk of post-LT recurrence and complications; they cannot be used in patients with decompensated cirrhosis. Ribavirin interferon alpha 1 Homo sapiens
2 Currently, interferon (IFN)-based regimens can be used in dual-agent regimens with ribavirin, in triple-agent antiviral strategies with direct-acting antivirals (e.g., protease inhibitors telaprevir or boceprevir), or before transplant in compensated patients to reduce HCV viral load to prevent or reduce the risk of post-LT recurrence and complications; they cannot be used in patients with decompensated cirrhosis. Ribavirin interferon alpha 1 Homo sapiens